We demonstrate real-time in vivo fundus imaging capabilities of our fluorescence lifetime imaging technology for the first time. This implementation of lifetime imaging uses light emitting diodes to capture full-field images capable of showing direct tissue contrast without executing curve fitting or lifetime calculations. Preliminary results of fundus images are presented, investigating autofluorescence imaging potential of various retina biomarkers for early detection of macular diseases. © 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)
Imaging autofluorescence temporal signatures of the human ocular fundus in vivo
Fluorescence lifetime imaging microscopy is a robust imaging modality that has been proven to be sensitive in the detection of chemicals and molecular species in the cluttered environments. [1] [2] [3] The examples specific to biomedical imaging are the detection of cancerous tumors 4, 5 and metabolic changes in the human fundus, aimed to characterize and provide better disease prognosis. Research efforts in the field reported various fluorescence biomarkers and structural contrast mechanisms to investigate detection capabilities for age-related macular degeneration (AMD), diabetic retinopathy, etc. [6] [7] [8] [9] [10] [11] [12] These systems utilize point detection by raster scanning and result in long acquisition and processing times. Our group has developed a new imaging method utilizing autofluorescence temporal signatures to test the efficacy of a direct image contrast in various tissues. This technique does not require setting a priori assumptions on the fluorescence decay behavior and displays a contrast map based on relative changes in lifetime (Fig. 1) . The contrast image can be acquired and processed in less than a second. 5, 13, 14 In this letter, we demonstrate the system's capability in imaging full-field human fundus with low-excitation fluence and show structural variations in vivo.
System and Methods
The illumination scheme in the system relies on a wide-field illumination by a diffused light emitting diode (LED) light providing excitation at 407 nm. Using this wavelength in imaging, the retina is possible in pseudophakic patients, as the intraocular lens efficiently transmits blue wavelengths and assists in reducing the autofluorescence signal found in crystalline lenses. 15, 16 Blue wavelengths have also been reported to efficiently excite metabolic fluorophores such as flavin adenine dinucleotide and lipofuscin, among other fluorophores in the retina and pigment epithelium, with strong signals from structural fluorophores, collagen, and elastin. 12, [17] [18] [19] These signals exhibit a broad fluorescence emission spectrum that can be imaged using our detection scheme and potentially used to detect structural and metabolic changes in the retina. The system was built on an existing fundus camera (Zeiss, FF4), which uses conventional optics (not confocal) with an indirect illumination scheme to record color images and fluorescein angiographs from a human retina. Modifications were made to enable imaging of the retina's autofluorescence signals ( Fig. 2 ) and include an intensified CCD (ICCD) imager (Andor, iStar 334T) and an LED (Thorlabs, LED405E) set to emit 20-ns long square pulses with 407-nm wavelength and average power of 4 μW at the cornea. Utilizing a blue wavelength with low power levels and flattop pulses with low average and peak power has been found safe both by the ANSI standard for ocular exposure 20,21 and reported DNA-damage threshold statistics. 22 The LED light passes through two ultraviolet (UV) optical filters (Thorlabs, FEL0400) to ensure no residual UV light reaches the imaged eye. Another filter is positioned in front of the ICCD to block reflected light and record fluorescence signals from the retina at a central wavelength of 460-and 60-nm bandwidth (Semrock, FF01-460/60-25). A high-power pulse generator (Avtech, AVR-E3-B-P) drives the LED and triggers the camera operation. The relatively low duty cycle (<0.2%) and the LED impedance matching network ensure optical output without damaging the LED and maintain wavelength stability for extended periods.
Results and Discussion
Ex vivo porcine eyes were used as a calibration model for the camera before in vivo experiments were performed, as they exhibit similar properties to the human eye. Six fresh eyes, kept in ice to slow tissue deterioration and delivered within 2 h of harvesting, were acquired from a local slaughterhouse in adherence to the Association for Research in Vision and Ophthalmology statement for the use of animals in ophthalmic and vision research. No Institutional Review Board approval was required. The chosen excitation wavelength transmits through the intraocular structures, i.e., lens and vitreous, and excites the retina and blood vessels (Fig. 3) .
All of the porcine eyes resulted in low-detail images due to various degrees of corneal edema (high hydration levels that cause opaqueness). Contrast in these images originates primarily from the lifetime difference between blood vessels and retinal connective tissue fluorophores, collagen, and elastin. The contribution of the lens' strong autofluorescence signal could explain variations in contrast. 17 The in vivo imaging experiment included six pseudophakic volunteer patients from the Stein Eye Institute at University of California, Los Angeles. The experiment was approved by the Internal Review Board for human subjects. Three out of the six patients were imaged successfully during system optimization and operator training. Two of the patients were diagnosed with dry AMD [Figs. 4(a)-4(c) and 4(g)-4(i)] and one patient with diabetic retinopathy [ Figs. 4(d) -4(f)]. Images of the diabetic patient show low signal levels and bright spots (hyperfluorescence) of macular edema. 23 The fluorescence intensity map shows better contrast than the lifetime data, and more data are needed in order to validate possible imaging utility for this condition. The first AMD patient [Figs. 4(a)-4(c)] displays high noise level, though the basic lifetime contrast between the optic disk and the surrounding retina is visible. Figures 4(b) and 4(c) were taken at different times. Images of the second AMD patient [Figs. 4(g)-4(i)] exhibit higher detail level and contrast due to optics optimizations. The lifetime image [ Fig. 4(h) ] shows signals of the optic disk and blood vessels' margins generated mainly from connective tissue fluorophores. Longer lifetime values in the fovea region are also visible and correlate to previously reported lifetime changes in AMD patients. 24 However, more patient data are needed in order to demonstrate reproducibility and statistical significance. The current fundus camera was not designed for lifetime imaging and has low photon efficiency, though basic fluorescence lifetime data displayed show the robustness of the technique. Diagnosis of AMD, specifically lipofuscin distribution, could possibly be achieved with a modern fundus imager that has higher photon efficiency and reduced reflections.
Conclusions
We have shown a proof of concept of our technique in imaging retina autofluorescence lifetime signatures. Implementation of this imaging method on a modern fundus camera could offer an alternative to existing technologies, using fast fundus imaging without raster scanning. Further improvement of the illumination pulse profile and algorithm optimizations could extract more information and increase signal-to-noise ratio. Implementation of multispectral excitation schemes in future research efforts could also provide better discrimination and contrast of endogenous fluorophores to detect metabolic processes and morphological changes in point of care macular diagnosis. Each image is acquired by the accumulation of many repetitive pulses by the gated camera to achieve adequate signal level. (b) The decay image is divided by the calibration image using pixel division and results in a final relative (normalized) lifetime image. High signal levels can be achieved, since the fluorescence intensity is recorded over a relatively long acquisition period (10 to 20 ns) and with good cameragating efficiency (>90%). Since the fluorophore lifetime and recorded signals are correlated, this algorithm produces lifetime contrast information without depending on yield or concentration factors. Fig. 2 Modified fundus camera schematics: light emitting diode (LED) and an intensified CCD (ICCD) are set to generate and capture nanosecond autofluorescence signals from the retina. The LED replaces a xenon flash bulb and the ICCD replaces a conventional CCD module; both were used in traditional angiography procedures. Images captured by pulsing the LED and synchronizing the ICCD by the pulse generator. The ICCD is capable of intensifying and imaging the signals to provide full-field images without raster scanning in real time.
